Novo Nordisk has launched the Wegovy pill in the US, offering a 1.5 mg starter dose of semaglutide, expanding its weight-loss treatment options. The pill, approved by the FDA, aims to regain market share against Eli Lilly’s upcoming Mounjaro pill.
Novo Nordisk has launched the Wegovy pill in the US, offering a 1.5 mg starter dose of semaglutide, expanding its weight-loss treatment options. The pill, approved by the FDA, aims to regain market share against Eli Lilly’s upcoming Mounjaro pill. by Soban News (international And National News)